Surgical treatment of diabetic retinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 242, Issue 8, 2004, Pages 704-709

  Helbig, Horst ^a   Sutter, Florian K P ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE;

CATARACT; CLINICAL FEATURE; DIABETIC RETINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; LASER SURGERY; LENS IMPLANTATION; MEDICAL INSTRUMENTATION; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA CAPILLARY; RETINA DETACHMENT; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING; VITRECTOMY;

DIABETIC RETINOPATHY; HUMANS; VITRECTOMY;

EID: 4544227714     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0977-9     Document Type: Review

References (30)

1. Bartz-Schmidt KU, Thumann G, Psichias A, Krieglstein GK, Heimann K (1999) Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 237:969-975
2. Benson GT, Flynn HW, Blankenship GW (1989) Posterior chamber intraocular lens implantation during diabetic pars plana vitrectomy. Ophthalmology 96:603-610
3. Blankenship GW (1980) The lens influence on diabetic vitrectomy results. Report of a prospective randomized study. Arch Ophthalmol 98:2196-2198
4. Charles S, Flinn CE (1981) The natural history of diabetic extramacular traction retinal detachment. Arch Ophthalmol 99:66-68
5. Diabetes Control and Complications Trial Research Group (1995) Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 102:647-661
6. Diabetic Retinopathy Vitrectomy Study Group (1990) Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol 108:958-964
7. Donnelly R, Idris I, Forrester JV (2004) Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research. Br J Ophthalmol 88:145-151
8. Elliott A, Flanagan D (1990) Macular detachment following laser treatment of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 228:438-441
9. Gandorfer A, Kampik A (2000) Pars plana vitrectomy in diabetic retinopathy. From pathogenetic principle to surgical strategy. Ophthalmologe 97:325-330
10. Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126-133
11. von Graefe A (1863) Perforation von abgelösten Netzhäuten und Glaskörpermembranen. Graefes Arch Ophthalmol 9:84-104
12. Helbig H, Kellner U, Bornfeld N, Foerster MH (1996) Grenzen und Möglichkeiten der Glaskörperchirurgie bei diabetischer Retinopathie. Ophthalmologe 93:647-654
13. Helbig H, Kellner U, Bornfeld N, Foerster MH (1998) Rubeosis iridis after vitrectomy for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 236:730-733
14. Hoerauf H, Roider J, Bopp S, Lucke K, Laqua H (1995) Endotamponade with silicon oil in severe proliferative retinopathy with attached retina. Ophthalmologe 92:657-662
15. Ikeda T, Sawa H, Koizumi K, Yasuhara T, Kinoshita S, Tano Y (1998) Vitrectomy for proliferative diabetic retinopathy with asteroid hyalosis. Retina 18:410-414
16. Jaccoma EH, Conway BP, Campochiaro PA (1985) Cryotherapy causes extensive breakdown of the blood-retinal barrier - a comparison with argon photocoagulation. Arch Ophthalmol 103:1728-1730
17. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S (2001) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 131:468-471
18. Körner F, Körner U (1988) Diabetische Retinopathie und Photokoagulation. Enke, Stuttgart
19. Lahey JM, Francis RR, Kearney JJ (2003) Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology 110:1335-1339
20. Laqua H (1980) Rubeosis iridis following pars plana vitrectomy. Klin Monatsbl Augenheilkd 177:24-30
21. Machemer R, Buettner H, Norton RWD, Parel JM (1971) Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 75:813-820
22. Messmer E, Bornfeld N, Oehlschlager U, Heinrich T, Foerster MH, Wessing A (1992) Epiretinal membrane formation after pars plana vitrectomy in proliferative diabetic retinopathy. Klin Monatsbl Augenheilkd 200:267-272
23. Meyer-Schwickerath G (1959) Lichtkoagulation. Enke, Stuttgart
24. Nasrallah FP, Jalkh AE, Van Coppenolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335-1339
25. Pauleikhoff D, Engineer B, Wessing AS (1997) Die Kryokoagulation in der Therapie der proliferativen diabetischen Retinopathie. Klin Monatsbl Augenheilkd 210:147-152
26. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130:178-186
27. Shinoda K, O'Hira A, Ishida S, Hoshide M, Ogawa LS, Ozawa Y, Nagasaki K, Inoue M, Katsura H (2001) Posterior synechia of the iris after combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation. Jpn J Ophthalmol 45:276-280
28. Smiddy WE, Flynn HW Jr (1999) Vitrectomy in the management of diabetic retinopathy. Surv Ophthalmol 43:491-507
29. Thompson JT, de Bustros S, Michels RG, Rice TA (1987) Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment. Arch Ophthalmol 105:503-507
30. United Kingdom Prospective Diabetes Study Group (1998) Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853.